ClinicalTrials.gov record
Recruiting Phase 2Phase 3 Interventional

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

ClinicalTrials.gov ID: NCT07440225

Public ClinicalTrials.gov record NCT07440225. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 7:00 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized Double-masked, Multicenter, 3-arm, Pivotal Phase 2/3 Study to Evaluate the Efficacy and Safety of Intravitreal (IVT) EYE201/MK-8748 Compared to Aflibercept (2 mg) in Participants With Neovascular Age-related Macular Degeneration (NVAMD)

Study identification

NCT ID
NCT07440225
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
EyeBiotech Ltd.
Industry
Enrollment
960 participants

Conditions and interventions

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 26, 2026
Primary completion
Jun 29, 2028
Completion
Jun 29, 2028
Last update posted
May 3, 2026

2026 – 2028

United States locations

U.S. sites
30
U.S. states
15
U.S. cities
27
Facility City State ZIP Site status
Retina Partners of Northwest Arkansas, PLLC Springdale Arkansas 72764 Recruiting
Global Research Management, Inc. Glendale California 91204 Recruiting
Retinal Consultants Medical Group (Site 024) Modesto California 95356 Recruiting
Retina Consultants of Southern California (Site 043) Redlands California 92374 Recruiting
Retinal Consultants Medical Group (Site 020) Sacramento California 95825 Recruiting
Retinal Consultants Medical Group (Site 022) Sacramento California 95841 Recruiting
Retina Group of Florida (Site 070) Fort Lauderdale Florida 33308 Recruiting
Fort Lauderdale Eye Institute (Site 042) Plantation Florida 33324 Recruiting
Retina Vitreous Associates of Florida (Site 049) St. Petersburg Florida 33711 Recruiting
Retina Associates of Florida, LLC Tampa Florida 33609 Recruiting
Retina Vitreous Associates of Florida Tampa Florida 33617 Recruiting
Illinois Retina Associates Oak Park Illinois 60304 Recruiting
Cumberland Valley Retina Consultants (Site 007) Hagerstown Maryland 21740 Recruiting
Foundation for Vision Research (Site 073) Grand Rapids Michigan 49546 Recruiting
Mississippi Retina Associates (Site 084) Madison Mississippi 39110 Recruiting
ong Island Vitreoretinal Consultants / Vitreoretinal Consultants of NY (Site 105) Hauppauge New York 11788 Recruiting
Retina Vitreous Surgeons of CNY, PC (Site 033) Liverpool New York 13088 Recruiting
Tulsa Retina Consultants Tulsa Oklahoma 74114 Recruiting
EyeHealth Northwest Portland Oregon 97225 Recruiting
Palmetto Retina Center Aiken South Carolina 29803 Recruiting
Charleston Neuroscience Institute - Bluffton (Site 124) Bluffton South Carolina 29910 Recruiting
Charleston Neuroscience Institute (Site 104) Charleston South Carolina 29414 Recruiting
Retina Research Institute of Texas (Site 010) Abilene Texas 79606 Recruiting
Austin Research Center for Retina Austin Texas 78705 Recruiting
Austin Retina Associates (Site 012) Austin Texas 78705 Recruiting
Texas Retina (Site 037) Plano Texas 75075 Recruiting
Retina Consultants of Texas (Site 014) The Woodlands Texas 77384 Recruiting
Retina Associates of Utah Salt Lake City Utah 84107 Recruiting
Piedmont Eye Center (Site 054) Lynchburg Virginia 24502 Recruiting
Pacific Northwest Retina (Site 112) Burlington Washington 98233 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07440225, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 3, 2026 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07440225 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →